University of California San Francisco

Drug rash with eosinophilia and systemic symptoms to anti-tuberculosis therapy: A retrospective review of inpatients at an academic medical centre in the United States. (38577046)

Gutierrez RA, Kazmi M, Fox L, Shinkai K, Arakaki R, Dobry A, Haemel A PMID: 38577046

Drug rash with eosinophilia and systemic symptoms to anti-tuberculosis therapy: A retrospective review of inpatients at an academic medical centre in the United States. (38577046)

Gutierrez RA, Kazmi M, Fox L, Shinkai K, Arakaki R, Dobry A, Haemel A PMID: 38577046

Drug rash with eosinophilia and systemic symptoms to anti-tuberculosis therapy: A retrospective review of inpatients at an academic medical centre in the United States. (38577046)

Gutierrez RA, Kazmi M, Fox L, Shinkai K, Arakaki R, Dobry A, Haemel A PMID: 38577046

Structural and Dynamic Analyses of Pathogenic Variants in PIK3R1 Reveal a Shared Mechanism Associated among Cancer, Undergrowth, and Overgrowth Syndromes. (38541623)

Dsouza NR, Cottrell CE, Davies OMT, Tollefson MM, Frieden IJ, Basel D, Urrutia R, Drolet BA, Zimmermann MT PMID: 38541623

Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability. (38543203)

Dragicevic N, Maibach HI PMID: 38543203

Comparison of large language models in generating patient handouts for the dermatology clinic: A blinded study. (38571697)

Chang CT, Ticknor IL, Spinelli JA, Bhatia BK, Marwaha S, Mirmirani P, Seidler AM, Man JR, McCleskey PE PMID: 38571697

Prevalence and risk factors for development of recurrent calciphylaxis. (38382710)

Xia J, Tan AJ, Gabel CK, Nguyen ED, Chand S, Rrapi R, Dobry AS, Garza-Mayers AC, Ko LN, Shah R, St John J, Nigwekar SU, Kroshinsky D PMID: 38382710

A core domain set for pyoderma gangrenosum trial outcomes: an international eDelphi and consensus study from the UPGRADE initiative. (37952167)

Jacobson ME, Rick JW, Gerbens LAA, Baghoomian W, Gould LJ, Marzano AV, Chen DM, Oakes DL, Dissemond J, Yamamoto T, Shinkai K, Nolan B, Lobato D, Thomas KS, Ortega-Loayza AG, UPGRADE PMID: 37952167

Distinct senescence mechanisms restrain progression of dysplastic nevi. (38371417)

Lorbeer FK, Rieser G, Goel A, Wang M, Oh A, Yeh I, Bastian BC, Hockemeyer D PMID: 38371417

Distinct senescence mechanisms restrain progression of dysplastic nevi. (38371417)

Lorbeer FK, Rieser G, Goel A, Wang M, Oh A, Yeh I, Bastian BC, Hockemeyer D PMID: 38371417